

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as PCOS, is a condition in which the body produces an imbalance of reproductive and metabolic hormones, particularly higher-than-normal androgen levels. These hormonal and metabolic changes can affect ovarian function, menstrual cycles, fertility, and overall health. PMOS can present with a wide range of features involving multiple body systems. Metabolic features include obesity, insulin resistance, prediabetes or type 2 diabetes, high blood pressure, abnormal lipid levels, fatty liver disease, cardiovascular risk, and sleep apnoea. Reproductive manifestations include irregular periods, ovulatory dysfunction, infertility, pregnancy-related complications, and increased risk of endometrial cancer. Psychological features may include anxiety, depression, poor quality of life, and eating disorders. Dermatological manifestations commonly include acne, excessive hair growth (hirsutism), and hair thinning or alopecia due to androgen excess. According to the World Health Organization (WHO), PMOS affects an estimated 8–13% of women of reproductive age, and up to 70% of cases are undiagnosed. Therefore, early diagnosis with the PMOS (formerly PCOS) Essential Package can aid in appropriate interventions and help prevent future complications.
The PMOS panel includes key hormonal and metabolic markers to comprehensively evaluate the polyendocrine and metabolic disturbances associated with the condition. HOMA-IR assesses insulin resistance, a central metabolic abnormality in PMOS contributing to hyperinsulinemia and androgen excess. HbA1c assesses long-term glucose control and helps identify insulin resistance, prediabetes, and diabetes risk. Follicle Stimulating Hormone (FSH) and Luteinising Hormone (LH) evaluate neuroendocrine and ovarian dysfunction, with altered LH–FSH balance commonly seen in PMOS. Serum Prolactin is included to exclude hyperprolactinemia as a cause of menstrual irregularity and ovulatory dysfunction. Total Testosterone helps detect biochemical hyperandrogenism, a defining feature of PMOS associated with acne, hirsutism, and ovulatory disturbances. Lipid Profile evaluates associated cardiometabolic risk including dyslipidaemia and future cardiovascular disease risk. TSH (Ultrasensitive) is included to identify underlying thyroid dysfunction, which can mimic or aggravate menstrual, metabolic, and reproductive abnormalities seen in PMOS.
You may get this test if you show symptoms suggestive of PMOS, such as irregular periods, abnormal hair growth, weight gain, hair loss, skin conditions such as acne, etc. It may also be done in individuals with risk factors for the condition, such as family history or obesity. Additionally, this package helps monitor treatment response in women already undergoing treatment for PMOS. An overnight fasting (8 to 12 hours) is required, along with other preparations depending on the number of tests included in this package. You are required to submit all the samples that are part of this package during the sample collection itself. Additionally, inform your doctor about any medications or supplements that you may be taking before undergoing for the PMOS (formerly PCOS) Essential Package as few of them may affect your test results, potentially requiring adjustments or temporary discontinuation before the test.
Talk to your doctor about your specific test results. The doctor might ask you to get additional tests done to determine the severity of your condition. After analyzing all the test results, the doctor would recommend a course of treatment and lifestyle modifications.
The PMOS (formerly PCOS) Essential Package is a holistic assessment of various health markers to understand the impact of PMOS on the body. The package includes Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Prolactin, Testosterone Total along with metabolic assessments like HbA1c, HOMA IR; Insulin Resistance Index, Lipid Profile and Thyroid Stimulating Hormone (TSH) Ultrasensitive. This comprehensive evaluation not only highlights hormonal disruptions but also underscores the importance of managing metabolic health in women with PMOS.
The PMOS Package helps women take charge of their health by spotting potential issues early and offering personalized management strategies, making it easier to deal with the challenges of PMOS.
The Follicle Stimulating Hormone test measures the level of FSH in your body. FSH is produced and subsequently released into the blood by the pituitary gland. Its production is controlled by a feedback mechanism involving a hormone situated in the hypothalamus in the brain. The released FSH travels through your blood and then attaches to receptors in the ovaries and testes. It exerts functional effects on the reproductive organs, such as sexual development, puberty, and maturation. FSH levels vary throughout the menstrual cycle in response to estradiol and progesterone. Any disruption or issue in this feedback mechanism can prevent the normal function of the testicles or ovaries. Thus, determining its level provides crucial information regarding your health.
Know more about Follicle Stimulating Hormone
The Serum Prolactin test measures how much prolactin hormone is in the blood. During pregnancy, prolactin works along with estrogen and progesterone to prepare the body for breastfeeding. After delivery, prolactin helps start and maintain milk production. If a woman does not breastfeed, her prolactin levels drop soon after birth.
Besides pregnancy, the most common cause of high prolactin is a prolactinoma. It is a non-cancerous tumor in the pituitary gland. These tumors are more common in women but can also occur in men. If the tumor becomes large, it may press on the optic nerve, causing headaches and vision problems. It can also affect the production of other hormones.
Know more about Serum Prolactin
The PMOS (formerly PCOS) Essential Package is done:
- To evaluate hormonal imbalances associated with PMOS.
- In women suffering from symptoms suggestive of PMOS, such as irregular periods, facial hair growth, unexplained weight gain, acne, skin darkening, and pain in the pelvis.
- In women with risk factors for PMOS, such as family history or obesity.
- In women facing issues in getting pregnant.
- To monitor response to treatment and adjust medications for PMOS as needed.
- To monitor the impact of PMOS on overall health, including the risk of diabetes, cardiovascular issues or thyroid disorders.
- To guide treatment options, lifestyle modifications, and fertility interventions if needed.
- Overnight fasting (8-12 hrs) is required. Do not eat or drink anything except water before the test.
- Do not stop taking your thyroid medications on the day of the test unless otherwise advised by the doctor.
- Sample to be given at the same time of the day in follow-up cases.
- In females, the preferred sampling time is day 2 or 3 of the menstrual cycle for LH & FSH.























